Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06808867 · ClinicalTrials.gov registry record · NA
Efficacy of Dietary Supplement in Subjects With Acid Reflux and/or Abdominal Bloating/Distention and GI Symptoms
A NA study, sponsored by Olly, PBC.
- Completed
- Registry status
- NA
- Development phase
- 85
- Enrollment target
NCT06808867: Completed NA study, sponsored by Olly, PBC.
NCT06808867 is a NA study that has completed, run by Olly, PBC. The registered enrollment target is 85 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06808867, a NA study, has completed, sponsored by Olly, PBC.
- COMPLETED
- Registry status
- NA
- Development phase
- 85 participants
- Enrollment target
Study Summary
This study was a prospective randomized clinical study. There was interventional treatment for a total of 8 weeks including a 2-week washout period. The subjects attended four appointments in the clinic throughout the duration of the study. Study Primary Objective: • To assess improvement in bloating symptoms Study Secondary Objectives: * To assess safety and tolerability of the formulation * To compare the time taken for perceptual improvement in bloating/distention * Enzyme blood assays * To assess quality of life indices
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Dietary Supplement with Active Ingredient Blend
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 85 participants |
| Start Date | 2024-02-25 |
| Est. Completion | 2024-04-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06808867
The ClinicalTrials.gov registry entry for NCT06808867 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 85 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Olly, PBC, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT06808867 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06808867 about?
NCT06808867 is a clinical study titled "Efficacy of Dietary Supplement in Subjects With Acid Reflux and/or Abdominal Bloating/Distention and GI Symptoms". This study was a prospective randomized clinical study. There was interventional treatment for a total of 8 weeks including a 2-week washout period. The subjects attended four appointments in the clinic throughout the duration of the study. Study Primary Objective: • To assess improvement in bloat...
What is the current status of trial NCT06808867?
This trial is currently completed. It is a NA study. The enrollment target is 85 participants. The study started on 2024-02-25. Estimated completion is 2024-04-15.
What interventions are being tested in trial NCT06808867?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Dietary Supplement with Active Ingredient Blend (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06808867?
This trial is sponsored by Olly, PBC, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.